Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background & Aims</h3><p>Worldwide, Nonalcoholic fatty liver disease (NAFLD) prevalence increases rapidly and becomes a major global health problem. Tumor necrosis factor‐α‐induced protein 8‐like 2 (TIPE2) plays a protective role in a cluster of liver diseases, such as autoimmune hepatitis, hepatitis B, and hepatocellular carcinoma. But the function of TIPE2 in NAFLD remained unknown. Here, we investigated the role of TIPE2 in the development of NAFLD.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach & Results</h3><p>Our study found in vitro overexpression or knockout of TIPE2 significantly ameliorated or aggravated lipid accumulation and inflammation in hepatocytes exposed to metabolic stimulation, respectively. Consistently, in vivo hepatic steatosis, insulin resistance, inflammation, and fibrosis were alleviated in hepatic TIPE2 transgenic mice but exaggerated in hepatic TIPE2 knockout mice treated by metabolic challenges. RNA sequencing revealed TIPE2 was significantly associated with the mitogen‐activated protein kinase (MAPK) pathway. Mechanistic experiments demonstrated that TIPE2 bound with transforming growth factor‐beta‐activated kinase 1 (TAK1) under metabolic stress, prevented tumor necrosis factor receptor‐associated factor 6 (TRAF6)‐mediated TAK1 ubiquitination and subsequently inhibited the phosphorylation and activation of TAK1‐c‐Jun NH2‐terminal kinase (JNK)/p38 signaling. Further investigation showed that blocking the activity of TAK1 reversed the worsening of hepatic metabolic disorders and inflammation in TIPE2‐HKO hepatocytes and mice treated with metabolic stimulation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>TIPE2 suppresses NAFLD advancement by blocking TAK1‐JNK/p38 pathway and is a promising target molecule for NAFLD therapy.</p></section>

Thioredoxin binding protein 2 modulates natural killer T cell-dependent innate immunity in the liver: possible link to lipid metabolism.

The Function of Thioredoxin-Binding Protein-2 (TBP-2) in Different Diseases

Overexpression of Thioredoxin-Binding Protein 2increases Oxidation Sensitivity and Apoptosis in Human Lens Epithelialcells

Shp-2 Phosphatase Negatively Regulates The Trif Adaptor Protein-Dependent Type I Interferon And Proinflammatory Cytokine Production

Thioredoxin Binding Protein-2 Regulates Autophagy of Human Lens Epithelial Cells under Oxidative Stress Via Inhibition of Akt Phosphorylation.

TIPE2 protein restrains invariant NKT activation and protects against immune-mediated hepatitis in mice

Thioredoxin Activity Confers Resistance Against Oxidative Stress In Tumor-Infiltrating Nk Cells

Trim30 Alpha Negatively Regulates Tlr-Mediated Nf-Kappa B Activation By Targeting Tab2 And Tab3 For Degradation

Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling.

Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice

Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice

Thioredoxin is a metabolic rheostat controlling regulatory B cells

Deficiency of thioredoxin-interacting protein results in age-related thrombocytopenia due to megakaryocyte oxidative stress

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook

TAK1 Binding Protein 2 Is Essential for Liver Protection from Stressors

Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?

Tumor Necrosis Factor α–Induced Protein 8–Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta–Activated Kinase 1 Activation

The β2 integrin CD11b attenuates polyinosinic:Polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions

Redox-Dependent And Independent Effects Of Thioredoxin Interacting Protein

Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis

CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice Via Membrane-Bound TGF-β and OX40